FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

REID CLIFFORD A

2. Date of Event Requiring Statement (MM/DD/YYYY)
11/10/2010 

3. Issuer Name and Ticker or Trading Symbol

COMPLETE GENOMICS INC [GNOM]

(Last)        (First)        (Middle)

C/O COMPLETE GENOMICS, INC., 2071 STIERLIN COURT

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
President, CEO & Director /

(Street)

MOUNTAIN VIEW, CA 94043-4655       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.001 par value   319200   I   By Living Trust   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)     (2) 11/12/2019   Common Stock   3090   $1.50   D    
Stock Option (right to buy)     (3) 12/27/2019   Common Stock   66666   $1.50   D    
Stock Option (right to buy)     (3) 2/23/2020   Common Stock   341667   $1.50   D    

Explanation of Responses:
( 1)  These shares are held by the Clifford A. Reid Living Trust, Dated September 3, 1997, Clifford A. Reid, Trustee.
( 2)  The shares vest pursuant to the following schedule: The shares subject to the option vest in 48 successive, equal monthly installments measured from April 1, 2009, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
( 3)  The shares vest pursuant to the following schedule: The shares subject to the option vest in 48 successive, equal monthly installments measured from August 12, 2009, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
REID CLIFFORD A
C/O COMPLETE GENOMICS, INC.
2071 STIERLIN COURT
MOUNTAIN VIEW, CA 94043-4655
X
President, CEO & Director

Signatures
/s/ Clifford A. Reid, Ph.D. 11/10/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Global X Genomics and Bi... Charts.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Global X Genomics and Bi... Charts.